Known targets — ChEMBL curated mechanism
CACNA1CCACNA1DCACNA1FCACNA1SDRD2HTR1BHTR1DHTR1F
The experimentally established mechanism targets of Malic Acid. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.
Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MTNR1A | P48039 | 17/20 | 0.60 |
| ▸ | MTNR1B | P49286 | 17/20 | 0.60 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.43 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.43 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.43 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.43 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.43 |
| ▸ | MAPT | P10636 | 1/20 | 0.43 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.43 |
| ▸ | HPGD | P15428 | 1/20 | 0.43 |
| ▸ | TSHR | P16473 | 1/20 | 0.43 |
| ▸ | NFKB1 | P19838 | 1/20 | 0.43 |
| ▸ | APEX1 | P27695 | 1/20 | 0.43 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.43 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.43 |
| ▸ | HIF1A | Q16665 | 1/20 | 0.43 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.43 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.43 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.43 |
| ▸ | MEN1 | O00255 | 1/20 | 0.39 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Oxalic Acid SCHEMBL3250917 | 0.90 | MTNR1A (0.67) | MTNR1AMTNR1BKDM4EALDH1A1CYP1A2 | |
| SCHEMBL3244549 | 0.88 | MTNR1A (0.66) | MTNR1AMTNR1BKDM4EALDH1A1CYP1A2 | |
| Maleic Acid SCHEMBL3250853 | 0.87 | MTNR1A (0.64) | MTNR1AMTNR1BKDM4EALDH1A1CYP1A2 | |
| Hydrochloric Acid SCHEMBL3245450 | 0.87 | MTNR1A (0.64) | MTNR1AMTNR1BKDM4EALDH1A1CYP1A2 | |
| Citric Acid SCHEMBL3253261 | 0.85 | MTNR1A (0.59) | MTNR1AMTNR1BKDM4EALDH1A1CYP1A2 | |
| SCHEMBL3257337 | 0.78 | MTNR1A (0.63) | MTNR1AMTNR1BKDM4EALDH1A1CYP1A2 | |
| SCHEMBL3256717 | 0.77 | MTNR1A (0.60) | MTNR1AMTNR1BKDM4EALDH1A1CYP1A2 | |
| Citric Acid SCHEMBL3248462 | 0.77 | MTNR1A (0.57) | MTNR1AMTNR1BKDM4EALDH1A1CYP1A2 | |
| Citric Acid SCHEMBL3248609 | 0.76 | MTNR1A (0.55) | MTNR1AMTNR1BKDM4EALDH1A1CYP1A2 | |
| SCHEMBL3251452 | 0.76 | MTNR1A (0.50) | MTNR1AMTNR1BKDM4EALDH1A1CYP1A2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-1537113-B9 | ARYLALKYL INDOLES HAVING SEROTONIN RECEPTOR AFFINITY USEFUL AS THERAPEUTIC AGENTS, PROCESS FOR THEIR PREPARATION AND PHARMACEUTICAL COMPOSITIONS CONTAINING THEM | SUVEN LIFE SCIENCES LTD (IN) | 2010-05-26 | — | — | EP | disclosed |